BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Treatment
21 results:

  • 1. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
    Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
    Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
    Duffau H
    J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Incidence of antibody-drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis.
    Zhu Z; Shen G; Li J; Qiu T; Fang Q; Zheng Y; Xin Y; Liu Z; Zhao F; Ren D; Zhao J
    Crit Rev Oncol Hematol; 2023 Apr; 184():103960. PubMed ID: 36907365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
    Dillon LW; Gui G; Page KM; Ravindra N; Wong ZC; Andrew G; Mukherjee D; Zeger SL; El Chaer F; Spellman S; Howard A; Chen K; Auletta J; Devine SM; Jimenez Jimenez AM; De Lima MJG; Litzow MR; Kebriaei P; Saber W; Weisdorf DJ; Hourigan CS
    JAMA; 2023 Mar; 329(9):745-755. PubMed ID: 36881031
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for lung Adenocarcinoma.
    Jin X; Hu Z; Sui Q; Zhao M; Liang J; Liao Z; Zheng Y; Wang H; Shi Y
    J Immunol Res; 2022; 2022():6555810. PubMed ID: 35812244
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Marsdenia tenacissima (Roxb.) Moon injection exerts a potential anti-tumor effect in prostate cancer through inhibiting ErbB2-GSK3β-HIF1α signaling axis.
    Chen X; Luo Z; Liu X; Li X; Li Q; Zhang W; Liu Y; Cheng Z; Yang X; Liu Y; Jin R; Zhu D; Wang F; Lu Q; Su Z; Guo H
    J Ethnopharmacol; 2022 Sep; 295():115381. PubMed ID: 35595220
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular and clinical characteristics of idh mutations in Chinese NSCLC patients and potential treatment strategies.
    Chen S; Zhu H; Jin M; Yuan H; Liu Z; Li J; Zhang X; Meng L; Li T; Diao Y; Gao H; Hong C; Zhu X; Zheng J; Li F; Niu Y; Ma T; Li X
    Cancer Med; 2022 Nov; 11(22):4122-4133. PubMed ID: 35526267
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
    Neumann JM; Freitag H; Hartmann JS; Niehaus K; Galanis M; Griesshammer M; Kellner U; Bednarz H
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):351-360. PubMed ID: 34839410
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
    Sánchez-Herrero E; Serna-Blasco R; Ivanchuk V; García-Campelo R; Dómine Gómez M; Sánchez JM; Massutí B; Reguart N; Camps C; Sanz-Moreno S; Calabuig-Fariñas S; Jantus-Lewintre E; Arnal M; Fernández-Orth D; Calvo V; González-Rumayor V; Provencio M; Romero A
    Mol Oncol; 2021 Sep; 15(9):2363-2376. PubMed ID: 34058070
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.
    Ross JS; Sokol ES; Moch H; Mileshkin L; Baciarello G; Losa F; Beringer A; Thomas M; Elvin JA; Ngo N; Jin DX; Krämer A
    Oncologist; 2021 Mar; 26(3):e394-e402. PubMed ID: 33219618
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
    Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
    [No Abstract]    [Full Text] [Related]  

  • 13. Belief in and use of traditional Chinese medicine in Shanghai older adults: a cross-sectional study.
    Xin B; Mu S; Tan T; Yeung A; Gu D; Feng Q
    BMC Complement Med Ther; 2020 Apr; 20(1):128. PubMed ID: 32345283
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
    Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
    Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Wild-type idh2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
    Li J; He Y; Tan Z; Lu J; Li L; Song X; Shi F; Xie L; You S; Luo X; Li N; Li Y; Liu X; Tang M; Weng X; Yi W; Fan J; Zhou J; Qiang G; Qiu S; Wu W; Bode AM; Cao Y
    Theranostics; 2018; 8(15):4050-4061. PubMed ID: 30128035
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Therapeutic strategies in patients undergoing surgery for non-small cell lung cancer. Results of the ESCAP-2011-CPHG study, promoted by the French College of General Hospital Respiratory Physicians (CPHG)].
    Pinquié F; Goupil F; Oster JP; Dixmier A; Renault PA; Lévy A; Mathieu JP; Paillot N; Goutorbe FC; Masson P; Molinier O; Debieuvre D; Grivaux M
    Rev Mal Respir; 2017 Nov; 34(9):976-990. PubMed ID: 29150179
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals].
    Grivaux M; Goupil F; Asselain B; Blanchon F; Collon T; Coëtmeur D; Dayen C; Locher C; Molinier O; Martin F; Debieuvre D
    Rev Mal Respir; 2017 Nov; 34(9):991-999. PubMed ID: 29111174
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: A meta-analysis.
    Juvet LK; Thune I; Elvsaas IKØ; Fors EA; Lundgren S; Bertheussen G; Leivseth G; Oldervoll LM
    Breast; 2017 Jun; 33():166-177. PubMed ID: 28415013
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.
    Zindler JD; Thomas CR; Hahn SM; Hoffmann AL; Troost EG; Lambin P
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26476075
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The CpG island methylator phenotype: what's in a name?
    Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
    Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.